DEFINE PCI Study One-year Data Show Potential of Treating Residual Ischemia to Improve Clinical Outcomes for Coronary Stent Patients

Amsterdam, the Netherlands, Oct. 15 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the one-year results of the DEFINE PCI [1] study at the Cardiology Research Foundation’s TCT Connect 2020 virtual conference. The DEFINE PCI study assessed the level of residual ischemia, or reduced blood flow to the heart [...]